1303996-68-0 | 5,5′-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6′-dichloro-3-hydroxy-3,3′-biindoline-2,2′-dione
Purity 98% Min.
Application pharmaceutical intermediate
• The above information is for reference only.
• For further more information, please email us [email protected].
5,5′-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6′-dichloro-3-hydroxy-3,3′-biindoline-2,2′-dione;
ZiprasidoneRelatedCoMpoundC;
5,5′-Bis[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6,6′-dichloro-1,1′,3,3′-tetrahydro-3-hydroxy-[3,3'-bi-2H-indole]-2,2′-dione;
ZiprasidoneEPImpurityD;
ZiprasidoneImpurity4(ZiprasidoneEPImpurity)D;
• The above information is for reference only.
• For further more information, please email us [email protected].
Write your message here and send it to us